Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Energy Dependent Transport of Xenobiotics and Its Relevance to Multidrug Resistance

Volume:3   Issue:2
Pp: 89-107
Rajendra Sharma, Yogesh C. Awasthi, Yusong Yang, Abha Sharma, Sharad S. Singhal and Sanjay Awasthi
DOI: 10.2174/1568009033482047

Increasing Complexity of Farnesyltransferase Inhibitors Activity: Role in Chromosome Instability

Volume:3   Issue:2
Pp: 109-118
Carla Falugi, Sonya Trombino, Pierluigi Granone, Stefano Margaritora and Patrizia Russo
DOI: 10.2174/1568009033482056

Survivin: Role in Normal Cells and in Pathological Conditions

Volume:3   Issue:2
Pp: 131-152
L. O'Driscoll, R. Linehan and M. Clynes
DOI: 10.2174/1568009033482038

Induction of Senescent-Like Growth Arrest as a New Target in Anticancer Treatment

Volume:3   Issue:2
Pp: 153-159
Xianghong Wang, Sai-Wah Tsao, Yong-Chuan Wong and Annie L.M. Cheung
DOI: 10.2174/1568009033482001

Erratum promotion: free to download

Volume:3   Issue:2
Pp: 161-161

DOI: 10.2174/1568009033482029